[Parvovirus B19. Position of the Blood Working Group of the Federal Ministry of Health].
D000328:Adult; D001771:Blood Banks / Q000706:statistics & numerical data*; D016913:Blood Component Transfusion / Q000009:adverse effects; D001782:Blood Donors / Q000706:statistics & numerical data*; D058731:Blood Safety; D017848:Blood-Borne Pathogens; D002648:Child; D002675:Child, Preschool; D021821:Communicable Diseases, Emerging / Q000517:prevention & control / Q000635:transmission* / Q000821:virology*; D003430:Cross-Sectional Studies; D004279:DNA, Viral / Q000032:analysis; D016731:Erythema Infectiosum / Q000635:transmission / Q000821:virology; D005260:Female; D005838:Genotype; D005858:Germany; D006801:Humans; D015994:Incidence; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008875:Middle Aged; D010322:Parvoviridae Infections / Q000517:prevention & control / Q000635:transmission* / Q000821:virology*; D016732:Parvovirus B19, Human / Q000235:genetics; D011247:Pregnancy; D065227:Transfusion Reaction; D038301:Virus Inactivation; D055815:Young Adult
D004279:DNA, Viral